Sanchez Ramiro has filed 5 insider transactions across 2 companies since November 2024.
Most recent transaction: a grant/award of 3806 shares of Alto Neuroscience, Inc. ($ANRO) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Alto Neuroscience, Inc. | $ANRO | Sanchez Ramiro | Director | A | Stock Option (right to buy) | 3806 | $11.82 | 3,806.0000 | 31,066,335 | 9999.99% | 0.01% |
| Aug. 12, 2025 | Alto Neuroscience, Inc. | $ANRO | Sanchez Ramiro | Director | A | Stock Option (right to buy) | 30574 | $0.00 | 30,574.0000 | 27,072,129 | 9999.99% | 0.11% |
| Aug. 12, 2025 | Alto Neuroscience, Inc. | $ANRO | Sanchez Ramiro | Director | A | Stock Option (right to buy) | 3928 | $2.21 | 3,928.0000 | 27,072,129 | 9999.99% | 0.01% |
| June 17, 2025 | Rapport Therapeutics, Inc. | $RAPP | Sanchez Ramiro | Not found | A | Stock Option (Right to Buy) | 10925 | $0.00 | 10,925.0000 | 36,496,437 | 9999.99% | 0.03% |
| Nov. 7, 2024 | Rapport Therapeutics, Inc. | $RAPP | Sanchez Ramiro | Not found | A | Stock Option (Right to Buy) | 29756 | $0.00 | 29,756.0000 | 0 | 9999.99% | 0.00% |